Janus Henderson Group Maintains Significant Stake in Bicycle Therapeutics
Ticker: BCYC · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 1761612
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, biotech, investment-firm
TL;DR
**Janus Henderson Group still owns Bicycle Therapeutics shares, signaling continued institutional confidence.**
AI Summary
Janus Henderson Group plc, a major investment firm, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership of American Depositary Shares in Bicycle Therapeutics plc as of December 31, 2023. This filing indicates that Janus Henderson Group plc continues to hold a significant stake in Bicycle Therapeutics, signaling their ongoing confidence in the company. For investors, this means a large institutional investor maintains a position, which can be seen as a positive sign of stability and potential future growth for Bicycle Therapeutics stock.
Why It Matters
This filing shows a major institutional investor, Janus Henderson Group plc, continues to hold shares in Bicycle Therapeutics, which can reassure current and potential investors about the company's long-term prospects.
Risk Assessment
Risk Level: low — This filing is an update on institutional ownership and does not introduce new risks to the company or its stock.
Analyst Insight
An investor should note that a major institutional player, Janus Henderson Group plc, continues to hold a position in Bicycle Therapeutics plc. While this doesn't guarantee future performance, it suggests ongoing institutional confidence. Investors might consider this as a data point when evaluating the stock, but should conduct further due diligence on Bicycle Therapeutics' fundamentals and future prospects.
Key Players & Entities
- Janus Henderson Group plc (company) — the reporting person and institutional investor
- Bicycle Therapeutics plc (company) — the subject company whose securities are being reported
- American Depositary Shares (other) — the class of securities owned by Janus Henderson Group plc
- December 31, 2023 (date) — the date of the event requiring the filing
- February 12, 2024 (date) — the filing date of the SC 13G/A amendment
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' in the filing values.
Who is the reporting person in this filing?
The reporting person is Janus Henderson Group plc, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: JANUS HENDERSON GROUP PLC'.
What company's securities are being reported on?
The securities of Bicycle Therapeutics plc are being reported on, as indicated by 'Name of Issuer: Bicycle Therapeutics plc'.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the American Depositary Shares of Bicycle Therapeutics plc is 088786108, as listed under 'CUSIP Number: 088786108'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under 'Date of Event Which Requires Filing of this Statement: 12/31/2023'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 12, 2024 regarding BICYCLE THERAPEUTICS plc (BCYC).